Many features of BRAF oncogene in papillary thyroid cancer have been elucidated. Many aspects still need to be clarified through prospective and randomized studies. However, BRAF mutation status in thyroid cancer appears as a promising marker to provide a basis for developing a personalized management
BRAF mutation assessment in papillary thyroid cancer: Are we ready to use it in clinical practice? / Puxeddu, Efisio; Filetti, Sebastiano. - In: ENDOCRINE. - ISSN 1355-008X. - STAMPA. - 45:3(2014), pp. 341-343. [10.1007/s12020-013-0139-0]
BRAF mutation assessment in papillary thyroid cancer: Are we ready to use it in clinical practice?
FILETTI, SEBASTIANO
2014
Abstract
Many features of BRAF oncogene in papillary thyroid cancer have been elucidated. Many aspects still need to be clarified through prospective and randomized studies. However, BRAF mutation status in thyroid cancer appears as a promising marker to provide a basis for developing a personalized managementFile allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
